Evidence map›Paper›PMID 34346558›Full record

ArticlePM & R : the journal of injury, function, and rehabilitation2021

Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients.

Joseph E Herrera, William N Niehaus, Jonathan Whiteson, Alba Azola, John M Baratta, Talya K Fleming, Soo Yeon Kim, Huma Naqvi, Sarah Sampsel, Julie K Silver and 4 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract readConsensus Statement
In one paragraph

Article in PM & R : the journal of injury, function, and rehabilitation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06821087 (Evaluating the Neuromodulatory Effect of Ketamine in Long COVID), which is not on this map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06821087 phase2completednot on this mapstarted 2025, after this paper: background citation

Evaluating the Neuromodulatory Effect of Ketamine in Long COVID: A Pilot Study Targeting Fatigue and Neurocognitive Symptoms

TypeinterventionalSponsorUniversity of Texas at AustinRan2025 to 2026Enrolled20ConditionsLong COVIDArmsKetamine only
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 132 citations in OpenAlex.

  1. Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Long COVID Symptom Management Through Self-Care and Nonprescription Treatment Options: A Narrative Review.International journal of environmental research and public health · 2025
    Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Persistent dysfunctions of brain metabolic connectivity in long-covid with cognitive symptoms.European journal of nuclear medicine and molecular imaging · 2025
    Article
  19. Article
  20. Observational

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 1 country.

Joseph E HerreraDepartment of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
William N NiehausDepartment of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Aurora, Colorado, USA.
Jonathan WhitesonDepartment of Rehabilitation Medicine and Department of Medicine, Rusk Rehabilitation, NYU Langone Health, New York, New York, USA.
Alba AzolaDepartment of Physical Medicine and Rehabilitation, Johns Hopkins Medicine, Baltimore, Maryland, USA.
John M BarattaDepartment of Physical Medicine and Rehabilitation, UNC-Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-1124-7928
Talya K FlemingJFK Johnson Rehabilitation Institute at Hackensack Meridian Health, Edison, New Jersey, USA.
Soo Yeon KimDepartment of Physical Medicine and Rehabilitation, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Huma NaqviHartford HealthCare's COVID Recovery Center, Hartford HealthCare Medical Group, Hartford, Connecticut, USA.
Sarah SampselSLSampsel Consulting, LLC, Albuquerque, New Mexico, USA.ORCID 0000-0002-7496-8482
Julie K SilverDepartment of Physical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Monica Verduzco-GutierrezDepartment of Rehabilitation Medicine, UT Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0003-0964-5908
Jason MaleyDivision of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Eric HermanDepartment of Family Medicine, School of Medicine, Oregon Health & Science University (OHSU), Portland, Oregon, USA.
Benjamin AbramoffDepartment of Physical Medicine and Rehabilitation, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Johns Hopkins University · USBeth Israel Deaconess Medical Center · USHackensack Meridian Health · USHartford Hospital · USHarvard University · USIcahn School of Medicine at Mount Sinai · USOregon Health & Science University · USRusk Rehabilitation · USThe University of Texas Health Science Center at San Antonio · USUniversity of Colorado Denver · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Disease ProgressionFatigueHumans

Identifiers

PMID34346558
PMCPMC8441628
OpenAlexW3192668131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.